Challenges Facing Healthcare Companies In Russia

BMI View: The modernisation of the country's healthcare system, a more favourable drug reimbursement regime and increasing consumer spending will be the main drivers behind growth in Russia's pharmaceutical market. However, tighter control of drug prices, government preference for domestically-produced medicines and concerns relating to intellectual property will impede expansion and hinder access for foreign drugmakers.

To read the full article, please choose one of the following options: